Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

This study has been completed.
Sponsor:
Collaborator:
Korea Research Institute of Bioscience & Biotechnology
Information provided by (Responsible Party):
Kyoo-Hyung Lee, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT00823524
First received: January 14, 2009
Last updated: February 18, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)